bioAffinity Technologies, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
bioAffinity Technologies, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2023.
  • bioAffinity Technologies, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.02M.
  • bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$345K, a 102% decline from 2022.
  • bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14.3M, a 331% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$345K -$14.7M -102% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $14.3M +$11M +331% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $3.33M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.